A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients

Journal of Clinical Hypertension

Volumn 12, Issue 9, 2010, Pages 666-677

  Bramlage, Peter ^a   Böhm, Michael ^b   Volpe, Massimo ^c,d   Khan, Bobby V ^g   Paar, W D ^g   Tebbe, Ulrich ^h   Thoenes, Martin ^e,f  

^a Institute for Cardiovascular Pharmacology and Epidemiology   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d IRCCS   (Italy)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f SANOFI   (France)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOLOGY; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NORTH AMERICA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 77956250061     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2010.00322.x     Document Type: Article

References (23)

1. Lopez AD, Mathers CD, Ezzati M. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
2. Schappert SM, Nelson C. National Ambulatory Medical Care Survey: 1995-96 Summary 1999, Washington, DC, DHHS Government Printing Office
3. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med 2000, 160:2281-2286.
4. Mancia G, De Backer G, Dominiczak A. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
5. Kearney PM, Whelton M, Reynolds K. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
6. Wolf-Maier K, Cooper RS, Kramer H. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004, 43:10-17.
7. Bakris G, Hill M, Mancia G. Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. J Hum Hypertens 2008, 22:63-70.
8. Bramlage P, Thoenes M, Kirch W. Clinical practice and recent recommendations in hypertension management--reporting a gap in a global survey of 1259 primary care physicians in 17 countries. Curr Med Res Opin 2007, 23:783-791.
9. Wolf-Maier K, Cooper RS, Banegas JR. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289:2363-2369.
10. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001, 345:479-486.
11. Berlowitz DR, Ash AS, Hickey EC. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998, 339:1957-1963.
12. Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich) 2000, 2:324-330.
13. Pittrow D, Kirch W, Bramlage P. Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol 2004, 60:135-142.
14. Bohm M, Thoenes M, Danchin N. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study. J Hypertens 2007, 25:2317-2324.
15. Messerli FH, Bangalore S, Julius S. Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation 2008, 117:2706-2715. discussion 2715
16. Sharma AM, Wittchen HU, Kirch W. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 2004, 22:479-486.
17. Silber S, Richartz BM, Goss F. Care of hypertensive patients seen by cardiologists: results of the Snapshot Hypertension Registry [in German]. Dtsch Med Wochenschr 2007, 132:2430-2435.
18. Chobanian AV, Bakris GL, Black HR. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003, 289:2560-2571.
19. Wiysonge CS, Bradley H, Mayosi BM. Beta-blockers for hypertension. Cochrane Database Syst Rev 2007, (1). CD002003
20. Stolk P, Van Wijk BL, Leufkens HG. Between-country variation in the utilization of antihypertensive agents: guidelines and clinical practice. J Hum Hypertens 2006, 20:917-922.
21. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005, 366:1545-1553.
22. Management of Hypertension in Adults in Primary Care: Partial Update. Costing Report: Implementing NICE Guidance in England National Institute for Health and Clinical Excellence (NICE), London, UK. June, 2006; NICE clinical guideline no. 34
23. Balkau B, Deanfield JE, Despres JP. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007, 116:1942-1951.